Showing results (151-160 of 162) with videos related to
Sort By:
Pageof 17
Med (New York, N.Y.)|March 16, 2022
A randomized, double-blind, placebo-controlled trial of intravenous alpha-1 antitrypsin for ARDS secondary to COVID-19Oliver J McElvaney, Natalie L McEvoy, Fiona Boland, et al.Ebiomedicine|February 26, 2022
Protease-anti-protease compartmentalization in SARS-CoV-2 ARDS: Therapeutic implicationsOisin F McElvaney, Takanori Asakura, Suzanne L Meinig, et al.American Journal of Human Genetics|April 14, 2009
Genetic control of human brain transcript expression in Alzheimer diseaseJennifer A Webster, J Raphael Gibbs, Jennifer Clarke, et al.Journal of Medicinal Chemistry|February 5, 2019
3,3'-Disubstituted 5,5'-Bi(1,2,4-triazine) Derivatives with Potent in Vitro and in Vivo Antimalarial ActivityLian Xue, Da-Hua Shi, Jitendra R Harjani, et al.Acta Neuropathologica|September 10, 2018
The genetic landscape of gliomas arising after therapeutic radiationGiselle Y López, Jessica Van Ziffle, Courtney Onodera, et al.The New England Journal of Medicine|June 5, 2023
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade GliomaIngo K Mellinghoff, Martin J van den Bent, Deborah T Blumenthal, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 4, 2023
Interactive Effects of Molecular, Therapeutic, and Patient Factors on Outcome of Diffuse Low-Grade GliomaShawn L Hervey-Jumper, Yalan Zhang, Joanna J Phillips, et al.American Journal of Respiratory and Critical Care Medicine|June 26, 2020
Characterization of the Inflammatory Response to Severe COVID-19 IllnessOliver J McElvaney, Natalie L McEvoy, Oisín F McElvaney, et al.JAMA Oncology|February 7, 2020
Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed GlioblastomaAnnette M Molinaro, Shawn Hervey-Jumper, Ramin A Morshed, et al.Brain : a Journal of Neurology|August 24, 2018
The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease targetVladislav A Petyuk, Rui Chang, Manuel Ramirez-Restrepo, et al.Pageof 17